mounjaro is tirzepatide second obesity drug to be approved for use in England | Obesity How Mounjaro® Works for Weight

GOLO expanded its litigation from trademark infringement to allege Goli Nutrition didnt submit evidence to support claims for its apple cider vinegar gummy supplements challenged in a review by an industry self-regulation program.

Discover how GLP-1 and GLP-1/GIP therapies (semaglutide and tirzepatide) influence body composition

THRIVE myGLP Dissolvable GLP-1 Activation Technology oral strips - a new way to support your weight management on-the-go for when you need natural GLP support.

Five clinical trials in type 2-diabetic subjects (SURPASS 15) have shown that tirzepatide at 515 mg per week reduces both HbA1c (1.24 to 2.58%) and body weight (5.411.7 kg) by amounts unprecedented for a single agent

The wild card-to-uncertainty about GLP-1 meds growth will be reimbursement: spending will continue to accelerate with upside if more widely reimbursed, IQVIA projects

Understanding how to handle timing delays helps you stay on track with your personalized GLP-1 therapy